Lymphoma Cancer News | Lymph Node Cancer Research Articles


Lymphoma News & Features

Featured Lymphoma Content

Lymphoma News & Features

Biosimilar Riabni Gets FDA Approval

The biosimilar has been approved for the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis.

Clinical Trials

Fact Sheets

Next post in Lymphoma